The effect and optimal dosage of medical cannabis are highly individual and influenced by several factors – including the endocannabinoid system, the type of disease, predominant symptoms, and other patient-specific characteristics. A precise, personalized therapy approach is therefore essential.

The N=1 principle emphasizes close collaboration between physicians and patients, allowing treatment to be flexibly adapted to individual needs.

CANMED is a digital platform designed to support physicians in Switzerland by providing resources to assist throughout the prescribing process:

1️⃣ Eligibility assessment
Available clinical evidence, contraindications, and potential drug interactions.

2️⃣ Determination of dosage and magistral preparation
Guidance on identifying suitable cannabinoid ratios and formulation options.

3️⃣ Prescription
Information on prescription requirements in accordance with Swiss regulations.

4️⃣ Reimbursement
Support with clarification of cost coverage by insurers.

5️⃣ Dispensing
Referral pathways to specialized pharmacies for preparation and delivery.

The CANMED platform is available in German and French to support physicians across Switzerland.